BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8910868)

  • 1. Mechanism for synergism between sulphonamides and trimethoprim clarified.
    Richards RM; Taylor RB; Zhu ZY
    J Pharm Pharmacol; 1996 Sep; 48(9):981-4. PubMed ID: 8910868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole.
    Then RL
    Rev Infect Dis; 1982; 4(2):261-9. PubMed ID: 7051228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of trimethoprim and sulphonamides: relevance to synergy in vivo.
    Lacey RW
    J Antimicrob Chemother; 1979 Nov; 5(B):75-83. PubMed ID: 317077
    [No Abstract]   [Full Text] [Related]  

  • 4. An evaluation of the antibacterial activities of combinations of sulfonamides, trimethoprim, dibromopropamidine, and silver nitrate compared with their uptakes by selected bacteria.
    Richards RM; Taylor RB; Xing DK
    J Pharm Sci; 1991 Sep; 80(9):861-7. PubMed ID: 1800710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility testing to trimethoprim alone and combined with sulphonamides.
    Dornbusch K; Gezelius L
    Chemotherapy; 1980; 26(6):418-26. PubMed ID: 7408555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim.
    Ekström B; Forsgren U; Ortengren B; Bergan T
    Infection; 1979; 7 Suppl 4():S359-66. PubMed ID: 389812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of synergism between combinations of ciprofloxacin, polymyxin, sulphadiazine and p-aminobenzoic acid.
    Richards RM; Xing DK
    J Pharm Pharmacol; 1993 Mar; 45(3):171-5. PubMed ID: 8097773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of sulphimidazole alone and in association with trimethoprim against enteric pathogens.
    Castelli M; Baggio G; Ruberto AI; Rossi T; Provvisionato A; Malagoli M; Bossa R; Galatulas I
    Pharmacol Res; 1992; 25(4):373-81. PubMed ID: 1409249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microbiological rationale for the combination of sulphonamides with trimethoprim.
    Grüneberg RN
    J Antimicrob Chemother; 1979 Nov; 5(B):27-36. PubMed ID: 536345
    [No Abstract]   [Full Text] [Related]  

  • 10. [Growth inhibition zones between polymyxin and sulphonamides].
    Breitfellner G
    Zentralbl Bakteriol Orig A; 1972 Aug; 221(3):357-66. PubMed ID: 4146475
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity testing with trimethorpim-sulphamethoxazole.
    Bushby SR
    Med J Aust; 1973 Jun; 1(2):Suppl:10-8. PubMed ID: 4199527
    [No Abstract]   [Full Text] [Related]  

  • 12. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
    Richards RM; Hamilton VE; Thomas MR
    J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of Pseudomonas aeruginosa to sulphonamides and trimethoprim and the activity of the combination trimethoprim: sulphamethoxazole.
    Grey D; Hamilton-Miller JM
    J Med Microbiol; 1977 Aug; 10(3):273-9. PubMed ID: 408490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessment of the rationale for the combinations of sulphonamides with diaminopyrimidines.
    Brumfitt W; Hamilton-Miller JM
    J Chemother; 1993 Dec; 5(6):465-9. PubMed ID: 8195839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 16. Present significance of resistance to trimethoprim and sulphonamides in coliforms, Staphylococcus aureus, and Streptococcus faecalis.
    Lewis EL; Lacey RW
    J Clin Pathol; 1973 Mar; 26(3):175-80. PubMed ID: 4633678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mafenide on dihydropteroate synthase.
    Eagon RG; McManus AT
    J Antimicrob Chemother; 1990 Jan; 25(1):25-9. PubMed ID: 2108114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethoprim and sulphonamides: laboratory studies.
    Bushby SR
    S Afr Med J; 1970 Aug; 44(32):Suppl:3-10. PubMed ID: 4990139
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacterial growth kinetics of E. coli in the presence of various trimethoprim derivatives alone and in combination with sulfonamides.
    Seydel JK; Wempe E
    Chemotherapy; 1980; 26(5):361-71. PubMed ID: 6993110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of composition of the culture media on the in vitro determination of the bacterial sensitivity to sulfonamides, trimethoprim and cotrimoxazole].
    Pessione E; Gaffodio AM; Martinetto P; Giunta C; Angeretti A
    Boll Ist Sieroter Milan; 1979 Jul; 58(3):234-41. PubMed ID: 518756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.